Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ephedra + apricot kernel is a traditional herbal drug combination commonly used in Chinese medicine, most notably as part of multi-herb formulas such as Ma Xing Shi Gan Tang (Ephedra Apricot Kernel Gypsum and Licorice Decoction). Ephedra (ma huang) contains alkaloids like ephedrine that act as bronchodilators and stimulants, while apricot kernel (xing ren), particularly the bitter variety, contains amygdalin and is used to relieve cough and wheezing. The combination is primarily indicated for respiratory conditions such as cough, asthma, bronchitis, pneumonia, and symptoms associated with lung heat or wind-heat/cold attacks. Mechanistically, Ephedra stimulates beta-adrenergic receptors leading to bronchodilation and increased lung ventilation; Apricot kernel helps suppress cough by dispersing lung qi downward. In TCM theory, this pair synergistically invigorates lung qi and relieves wheezing. Modern studies suggest that combining these herbs may modulate the absorption of active alkaloids from Ephedra—potentially reducing toxicity while maintaining efficacy[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ephedra + apricot kernel.